Table 2. Univariate and multivariate analyses of overall survival in ovarian cancer patients.
Univariate analysis | Multivariate analysis | |||
---|---|---|---|---|
Variables | Hazard ratio [95% CI] | p value | Hazard ratio [95% CI] | p value |
Age (> 50) | 2.20 [1.17–4.13] | 0.014 | 2.02 [1.02–3.98] | 0.043 |
FIGO stage (III/IV) | 4.72 [1.68–13.24] | 0.003 | 3.15 [1.08–9.18] | 0.036 |
Cell type (non-serous) | 0.31 [0.13–0.73] | 0.008 | 0.56 [0.23–1.34] | 0.193 |
Grade (poor) | 1.84 [1.00–3.39] | 0.049 | 1.73 [0.90–3.29] | 0.098 |
CA125 (> 35) | 1.97 [0.70–5.50] | 0.196 | NA | |
FILIP1L- | 3.04 [1.46–6.34] | 0.003 | 2.30 [1.03–5.15] | 0.043 |
Beta-catenin+ | 0.72 [0.40–1.30] | 0.283 | NA | |
SLUG+ | 1.80 [0.97–3.34] | 0.062 | NA | |
FILIP1L-/Beta-catenin+ | 2.80 [0.91–8.63] | 0.074 | NA | |
FILIP1L-/SLUG+ | 3.08 [1.27–7.47] | 0.013 | 2.77 [1.08 – 7.07] | 0.033 |
Beta-catenin+/SLUG+ | 1.36 [0.58–3.18] | 0.485 | NA |
Abbreviations: FIGO, International Federation of Gynecology and Obstetrics; CI, confidence interval; NA, not applicable.